1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Barrett Esophagus: new trials by email Literature Review of Barrett Esophagus trials Research Report on Barrett Esophagus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation Aspirin, Laboratory Biomarker Analysis, Placebo Administration - Barrett Esophagus, Esophageal Adenocarcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 21 | 2016-01-15 | 2026-09-11 |
Adenocarcinoma Of Esophagus (1)
Digestive System Diseases (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Neoplasms (1) · Precancerous Conditions (1)
Aspirin (1)
National Cancer Institute (NCI) (1)
Canada (1) · United States (1)
N01CN00034 (1), P30CA016672 (1)